PDS Biotechnology Corporation (PDSB)

NASDAQ

$1.15

$-0.08

(-6.85%)

Regular Market

PDS Biotechnology Corporation (PDSB) Live Price Chart

Last updated: ⁦2026-10-22 19:03:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

PDS Biotechnology Corporation (PDSB) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.15, with a market capitalization of $69.61M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.20 to $1.79. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$69.61M
Open	$1.16
Day's High	$17.85
Day's Low	$0.20
Previous Close	$1.24
Volume	4.23M
Average Volume	25.20M
P/E Ratio	--
52-Week High	$1.79
52-Week Low	$0.20
Dividend Yield	--
Earnings Date	--

PDS Biotechnology Corporation (PDSB) Stock Price Today

PDS Biotechnology Corporation (PDSB) is currently trading at $1.15 as of 2026-10-22 19:01:00, down 7.66% ($0.09) from the previous close of $1.24

During today's regular trading session, PDSB has traded between $0.20 and $17.85, with a trading volume of 4.23M shares. The current price is near the lower end of today's range.

PDS Biotechnology Corporation (PDSB) 7-Day Stock Price Change

Over the past seven days, PDS Biotechnology Corporation (PDSB) moved from $1.60 to $1.15, representing a decline of 28.44% ($0.46).

The stock traded between $0.90 and $1.79 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 10.19 million shares, down versus the previous seven-day period, indicating lower trading activity.

PDSB 52-Week Price Position

Position in Range: 59.6%

52W Low$0.20

52W High$1.79

PDSB is currently trading at $1.15, placing it 59.6% of the way from its 52-week low of $0.20 to its 52-week high of $1.79. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is PDS Biotechnology Corporation (PDSB)?

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.

PDS Biotechnology Corporation Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	21
Exchange	NASDAQ
Company Website	https://www.pdsbiotech.com

How to Buy PDS Biotechnology Corporation (PDSB) Stock on MEXC

Eligible investors can buy real shares of PDS Biotechnology Corporation (PDSB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for PDSB and Place Your Order

Open the RealStocks trading page and search for PDSB. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is PDS Biotechnology Corporation (PDSB) stock price today?

PDS Biotechnology Corporation (PDSB) is currently trading at $ 1.15, down 7.66% ($0.09) from the previous close of $ 1.24. Intraday prices update in real time during regular trading hours.

2.Is PDSB stock going up or down today?

As of 2026-10-22 19:01:00, PDSB is trading at $ 1.15, down 7.66% ($0.09) from its previous close of $ 1.24. The stock has traded between $ 0.20 and $ 17.85 during today’s regular session. Past price movements do not guarantee future results.

3.What is PDSB pre-market price?

As of 2026-10-22 19:01:00, PDSB is trading at $ 1.17 in pre-market trading, down 6.05% ($0.07) from the previous close of $ 1.24. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is PDSB after-hours price?

As of 2026-10-22 19:01:00, PDSB is trading at $ 1.16 in after-hours trading, down 6.85% ($0.08) from the regular-session close of $ 1.24. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is PDSB stock trading now?

PDSB trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does PDSB sit relative to its 52-week high and low?

Over the past 52 weeks, PDSB has traded between a low of $ 0.20 and a high of $ 1.79. At $ 1.15, the stock is positioned 59.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is PDS Biotechnology Corporation in?

PDS Biotechnology Corporation (PDSB) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is PDS Biotechnology Corporation's market capitalization and where is it listed?

PDS Biotechnology Corporation is listed on the NASDAQ exchange with a market capitalization of $ 69.61M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is PDSB valued in terms of P/E ratio and EPS?

PDSB trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.46. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does PDS Biotechnology Corporation pay a dividend?

PDS Biotechnology Corporation pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.